BioSpace News Archive

Ventex launched GN MEDI 99.9% antibacterial spray which is an eco-friendly and odorless product containing harmless minerals for sterilization and disinfection.

PCT LTD (OTC Pink: PCTL) (“PCTL”), as the result of its wholly owned operating company’s (PCT Corp.’s) growth, is pleased to announce a new distribution partner in Puerto Rico in addition to other ongoing expansion efforts.

A cross-sector group of 55 public health, health, labor, business and social policy organizations are jointly calling on the Trump Administration and Congress to pass and quickly implement a federal paid sick leave law that provides 14 days of such leave to all workers, available immediately upon declaration of a public health emergency.

GW Pharmaceuticals plc announces the submission of a Type II Variation Application to the European Medicines Agency seeking approval of EPIDYOLEX®, oral solution, for the treatment of seizures associated with Tuberous Sclerosis Complex, a rare genetic condition and a leading cause of genetic epilepsy.

BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), is now accepting specimens for testing of coronavirus disease 2019 (COVID-19) from healthcare providers, clinics and health systems throughout the United States.

Bausch Health Companies Inc. announced it will reduce debt by approximately $100 million through the prepayment of senior secured term loans, using cash generated from operations.

Lattice Biologics Ltd. (TSX-V: LBL) (OTCQB: LBLTF) (“Lattice Biologics” or the “Company”) today announced that it plans to evaluate its amniotic fluid concentrate, AmnioBoost, in patients with acute respiratory distress syndrome (ARDS) caused by coronavirus (COVID-19)

Seres Therapeutics, Inc. (Nasdaq: MCRB) today provided a statement on a safety alert from the U.S. Food and Drug Administration (FDA) regarding bloodstream infections with multi-drug resistant organisms (MDROs) transmitted through fecal microbiota transplantation (FMT).

Can-Fite to Support Research Directed by Kamel Khalili, Ph.D. on Piclidenoson against Coronaviruses.

VitalHub Corp. (the “Company” or “VitalHub”) (TSXV: VHI) announced today the development of a patient flow and data visibility solution to assist in response to the evolving COVID-19 crisis.